Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis.

Tim HarrisonGiorgio Walter CanonicaGeoffrey ChuppJason LeeFlorence SchleichTobias WelteAntonio ValeroKim GemzoeAoife MaxwellSandra JoksaiteShibing YangPeter HowarthMelissa K Van Dyke

Published in: The European respiratory journal (2020)

These data demonstrate that the effectiveness of mepolizumab is consistent with clinical trial results under real-world settings, with significant reductions in exacerbations and daily maintenance OCS dose.

Keyphrases

clinical trial
chronic obstructive pulmonary disease
randomized controlled trial
systematic review
cystic fibrosis
physical activity
study protocol
double blind
artificial intelligence